Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Induction of Clinical Response in UC
NCT01494857Phase 3Unknown
- Sponsor
- Clalit Health Services
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in ulcerative colitis (UC), sponsored by Clalit Health Services. Status: unknown.
02
Drugs
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01494857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01494857.